These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Subacute sclerosing panencephalitis should be eliminated by measles vaccination. Liu WL; He ZX; Li F; He D; Ai R Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182 [TBL] [Abstract][Full Text] [Related]
11. Measles vaccination and risk of SSPE. Agarwal RK Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848 [No Abstract] [Full Text] [Related]
12. Subacute sclerosing panencephalitis: a preventable disease that needs to be prevented. Bale JF Neurology; 2004 Oct; 63(8):1352-3. PubMed ID: 15505147 [No Abstract] [Full Text] [Related]
13. [Reasons for vaccinating against measles]. Celers J; Netter R Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595 [No Abstract] [Full Text] [Related]
14. Review of the effect of measles vaccination on the epidemiology of SSPE. Campbell H; Andrews N; Brown KE; Miller E Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676 [TBL] [Abstract][Full Text] [Related]
15. Subacute sclerosing panencephalitis in children: prevalence in South China. Ip P; Chung BH; Wong VC; Chan KY Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492 [TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of subacute sclerosing panencephalitis in infants: a collateral effect of under-vaccination. Pittet LF; Posfay-Barbe KM Clin Microbiol Infect; 2020 Jun; 26(6):662-664. PubMed ID: 32088332 [No Abstract] [Full Text] [Related]